SHIRE PLC: Director/PDMR Shareholding

Director/PDMR Share Dealings 
September 30, 2013 - Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Graham
Hetherington was granted on September 27, 2013, under the Shire Sharesave
Scheme, an option over 467 ordinary shares at an exercise price of £19.24 per
This notification relates to disclosures made in accordance with 3.1.4(R)(1)(a)
of the Disclosure and Transparency Rules. 
Tony Guthrie
Deputy Company Secretary 
For further information please contact: 
Investor Relations                                                              
Eric Rojas                         +1 781 482 0999    
Sarah Elton-Farr               +44 1256 894157    
Notes to editors 
Shire enables people with life-altering conditions to lead better lives. 
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs. 
We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal,
Internal Medicine and Regenerative Medicine and we are developing treatments
for symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas. 
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX 
Press Release                                      
-0- Sep/30/2013 15:15 GMT
Press spacebar to pause and continue. Press esc to stop.